No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Roth MKM Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $8
Sector Update: Health Care Stocks Slipping in Afternoon Trading
Niagen Says Its Operations Remain Resilient Amid Recent Tariff Developments
Niagen Bioscience (NAGE) Gets a Buy From Roth MKM
Investors Appear Satisfied With Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Prospects As Shares Rocket 29%
H.C. Wainwright Maintains Niagen Bioscience(NAGE.US) With Buy Rating, Maintains Target Price $11